UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTION 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 000-28401

 

 

Maxygen, Inc.

(Exact name of registrant as specified in its charter)

 

 

411 Borel Avenue, Suite 616

San Mateo, CA 94402

(650) 241-2292

(Address, including, zip code and telephone number, including area code, of registrant’s principal executive offices)

Common Stock, $0.0001 par value per share

(Title of each class of securities covered by this Form)

None

(Title of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)   x
Rule 12g-4(a)(2)   ¨
Rule 12h-3(b)(1)(i)   x
Rule 12h-3(b)(1)(ii)   ¨
Rule 15d-6   ¨

Approximate number of holders of record as of the certification or notice date: 244

Pursuant to the requirements of the Securities Exchange Act of 1934, Maxygen, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: November 1, 2013   Maxygen, Inc.
  By:  

/s/ Isaac Stein

   

Isaac Stein

Chief Executive Officer & Chief Financial

Officer

 

 

 

Maxygen, Inc. (MM) (NASDAQ:MAXY)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Maxygen, Inc. (MM).
Maxygen, Inc. (MM) (NASDAQ:MAXY)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Maxygen, Inc. (MM).